Nanotechnology in corneal neovascularization therapy - A review

Lilian Gonzalez, Raymond J. Loza, Kyu Yeon Han, Suhair Sunoqrot, Christy Cunningham, Patryk Purta, James Drake, Sandeep Jain, Seungpyo Hong, Jin Hong Chang

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Nanotechnology is an up-And-coming branch of science that studies and designs materials with at least one dimension sized from 1-100 nm. These nanomaterials have unique functions at the cellular, atomic, and molecular levels.1 The term "nanotechnology" was first coined in 1974.2 Since then, it has evolved dramatically and now consists of distinct and independent scientific fields. Nanotechnology is a highly studied topic of interest, as nanoparticles can be applied to various fields ranging from medicine and pharmacology, to chemistry and agriculture, to environmental science and consumer goods.3 The rapidly evolving field of nanomedicine incorporates nanotechnology with medical applications, seeking to give rise to new diagnostic means, treatments, and tools. Over the past two decades, numerous studies that underscore the successful fusion of nanotechnology with novel medical applications have emerged. This has given rise to promising new therapies for a variety of diseases, especially cancer. It is becoming abundantly clear that nanotechnology has found a place in the medical field by providing new and more efficient ways to deliver treatment. Ophthalmology can also stand to benefit significantly from the advances in nanotechnology research. As it relates to the eye, research in the nanomedicine field has been particularly focused on developing various treatments to prevent and/or reduce corneal neovascularization among other ophthalmologic disorders. This review article aims to provide an overview of corneal neovascularization, currently available treatments, and where nanotechnology comes into play.

Original languageEnglish
Pages (from-to)124-134
Number of pages11
JournalJournal of Ocular Pharmacology and Therapeutics
Volume29
Issue number2
DOIs
Publication statusPublished - 2013 Mar 1

Fingerprint

Corneal Neovascularization
Nanotechnology
Nanomedicine
Therapeutics
Nanostructures
Ophthalmology
Ecology
Agriculture
Research
Nanoparticles
Medicine
Pharmacology

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Gonzalez, L., Loza, R. J., Han, K. Y., Sunoqrot, S., Cunningham, C., Purta, P., ... Chang, J. H. (2013). Nanotechnology in corneal neovascularization therapy - A review. Journal of Ocular Pharmacology and Therapeutics, 29(2), 124-134. https://doi.org/10.1089/jop.2012.0158
Gonzalez, Lilian ; Loza, Raymond J. ; Han, Kyu Yeon ; Sunoqrot, Suhair ; Cunningham, Christy ; Purta, Patryk ; Drake, James ; Jain, Sandeep ; Hong, Seungpyo ; Chang, Jin Hong. / Nanotechnology in corneal neovascularization therapy - A review. In: Journal of Ocular Pharmacology and Therapeutics. 2013 ; Vol. 29, No. 2. pp. 124-134.
@article{287f37bddece486a88407af0961a5279,
title = "Nanotechnology in corneal neovascularization therapy - A review",
abstract = "Nanotechnology is an up-And-coming branch of science that studies and designs materials with at least one dimension sized from 1-100 nm. These nanomaterials have unique functions at the cellular, atomic, and molecular levels.1 The term {"}nanotechnology{"} was first coined in 1974.2 Since then, it has evolved dramatically and now consists of distinct and independent scientific fields. Nanotechnology is a highly studied topic of interest, as nanoparticles can be applied to various fields ranging from medicine and pharmacology, to chemistry and agriculture, to environmental science and consumer goods.3 The rapidly evolving field of nanomedicine incorporates nanotechnology with medical applications, seeking to give rise to new diagnostic means, treatments, and tools. Over the past two decades, numerous studies that underscore the successful fusion of nanotechnology with novel medical applications have emerged. This has given rise to promising new therapies for a variety of diseases, especially cancer. It is becoming abundantly clear that nanotechnology has found a place in the medical field by providing new and more efficient ways to deliver treatment. Ophthalmology can also stand to benefit significantly from the advances in nanotechnology research. As it relates to the eye, research in the nanomedicine field has been particularly focused on developing various treatments to prevent and/or reduce corneal neovascularization among other ophthalmologic disorders. This review article aims to provide an overview of corneal neovascularization, currently available treatments, and where nanotechnology comes into play.",
author = "Lilian Gonzalez and Loza, {Raymond J.} and Han, {Kyu Yeon} and Suhair Sunoqrot and Christy Cunningham and Patryk Purta and James Drake and Sandeep Jain and Seungpyo Hong and Chang, {Jin Hong}",
year = "2013",
month = "3",
day = "1",
doi = "10.1089/jop.2012.0158",
language = "English",
volume = "29",
pages = "124--134",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "2",

}

Gonzalez, L, Loza, RJ, Han, KY, Sunoqrot, S, Cunningham, C, Purta, P, Drake, J, Jain, S, Hong, S & Chang, JH 2013, 'Nanotechnology in corneal neovascularization therapy - A review', Journal of Ocular Pharmacology and Therapeutics, vol. 29, no. 2, pp. 124-134. https://doi.org/10.1089/jop.2012.0158

Nanotechnology in corneal neovascularization therapy - A review. / Gonzalez, Lilian; Loza, Raymond J.; Han, Kyu Yeon; Sunoqrot, Suhair; Cunningham, Christy; Purta, Patryk; Drake, James; Jain, Sandeep; Hong, Seungpyo; Chang, Jin Hong.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 29, No. 2, 01.03.2013, p. 124-134.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Nanotechnology in corneal neovascularization therapy - A review

AU - Gonzalez, Lilian

AU - Loza, Raymond J.

AU - Han, Kyu Yeon

AU - Sunoqrot, Suhair

AU - Cunningham, Christy

AU - Purta, Patryk

AU - Drake, James

AU - Jain, Sandeep

AU - Hong, Seungpyo

AU - Chang, Jin Hong

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Nanotechnology is an up-And-coming branch of science that studies and designs materials with at least one dimension sized from 1-100 nm. These nanomaterials have unique functions at the cellular, atomic, and molecular levels.1 The term "nanotechnology" was first coined in 1974.2 Since then, it has evolved dramatically and now consists of distinct and independent scientific fields. Nanotechnology is a highly studied topic of interest, as nanoparticles can be applied to various fields ranging from medicine and pharmacology, to chemistry and agriculture, to environmental science and consumer goods.3 The rapidly evolving field of nanomedicine incorporates nanotechnology with medical applications, seeking to give rise to new diagnostic means, treatments, and tools. Over the past two decades, numerous studies that underscore the successful fusion of nanotechnology with novel medical applications have emerged. This has given rise to promising new therapies for a variety of diseases, especially cancer. It is becoming abundantly clear that nanotechnology has found a place in the medical field by providing new and more efficient ways to deliver treatment. Ophthalmology can also stand to benefit significantly from the advances in nanotechnology research. As it relates to the eye, research in the nanomedicine field has been particularly focused on developing various treatments to prevent and/or reduce corneal neovascularization among other ophthalmologic disorders. This review article aims to provide an overview of corneal neovascularization, currently available treatments, and where nanotechnology comes into play.

AB - Nanotechnology is an up-And-coming branch of science that studies and designs materials with at least one dimension sized from 1-100 nm. These nanomaterials have unique functions at the cellular, atomic, and molecular levels.1 The term "nanotechnology" was first coined in 1974.2 Since then, it has evolved dramatically and now consists of distinct and independent scientific fields. Nanotechnology is a highly studied topic of interest, as nanoparticles can be applied to various fields ranging from medicine and pharmacology, to chemistry and agriculture, to environmental science and consumer goods.3 The rapidly evolving field of nanomedicine incorporates nanotechnology with medical applications, seeking to give rise to new diagnostic means, treatments, and tools. Over the past two decades, numerous studies that underscore the successful fusion of nanotechnology with novel medical applications have emerged. This has given rise to promising new therapies for a variety of diseases, especially cancer. It is becoming abundantly clear that nanotechnology has found a place in the medical field by providing new and more efficient ways to deliver treatment. Ophthalmology can also stand to benefit significantly from the advances in nanotechnology research. As it relates to the eye, research in the nanomedicine field has been particularly focused on developing various treatments to prevent and/or reduce corneal neovascularization among other ophthalmologic disorders. This review article aims to provide an overview of corneal neovascularization, currently available treatments, and where nanotechnology comes into play.

UR - http://www.scopus.com/inward/record.url?scp=84875008467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875008467&partnerID=8YFLogxK

U2 - 10.1089/jop.2012.0158

DO - 10.1089/jop.2012.0158

M3 - Review article

C2 - 23425431

AN - SCOPUS:84875008467

VL - 29

SP - 124

EP - 134

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 2

ER -

Gonzalez L, Loza RJ, Han KY, Sunoqrot S, Cunningham C, Purta P et al. Nanotechnology in corneal neovascularization therapy - A review. Journal of Ocular Pharmacology and Therapeutics. 2013 Mar 1;29(2):124-134. https://doi.org/10.1089/jop.2012.0158